Inari Medical, Inc.
NARI

$3.25 B
Marketcap
$55.57
Share price
Country
$1.04
Change (1 day)
$66.61
Year High
$36.73
Year Low
Categories

Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

marketcap

P/E ratio for Inari Medical, Inc. (NARI)

P/E ratio as of 2023: -2252.78

According to Inari Medical, Inc.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -2252.78. At the end of 2022 the company had a P/E ratio of -114.75.

P/E ratio history for Inari Medical, Inc. from 2018 to 2023

PE ratio at the end of each year

Year P/E ratio
2023 -2252.78
2022 -114.75
2021 462.06
2020 202.79
2019 -1073.96
2018 -188.21